The WHO has added Cannabinoid Hyperemesis Syndrome yo its diagnostic manual, establishing a new dedicated ICD-10-CM diagnosis code for the health condition.

MIAMI, FL, UNITED STATES, December 30, 2025 /EINPresswire.com/ — AIdMD Technologies is pleased to announce the U.S. market launch of its artificial intelligence–powered healthcare platform, ...

Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...

Acupuncture is one modality within a much larger medical framework of TCM and related East Asian systems. In daily practice, ...

Dubai: Dubai International Airport (DXB) is gearing up for its busiest travel day of the festive season, with December 28 ...

Background Multiple long-term conditions (MLTCs) are common among individuals with heart failure (HF); however, the influence ...

Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

While many use marijuana for managing chronic pain or as a way to unwind at the end of the day, according to UW Medicine, ...

Seborrheic dermatitis is associated with other epithelial barrier diseases of the skin and beyond, including the respiratory, ...

A new study challenges what's long been assumed about genetic variants thought to always cause inherited blindness.

On Friday, the healthcare behemoth released results of three highly anticipated external reviews that drilled down on a ...